First Quadrant L P CA increased its position in USANA Health Sciences, Inc. (NYSE:USNA) by 18.6% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 22,059 shares of the company’s stock after buying an additional 3,459 shares during the period. First Quadrant L P CA owned about 0.09% of USANA Health Sciences worth $1,414,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Renaissance Technologies LLC boosted its position in shares of USANA Health Sciences by 7.9% in the first quarter. Renaissance Technologies LLC now owns 1,761,666 shares of the company’s stock worth $101,472,000 after buying an additional 128,766 shares in the last quarter. Teachers Advisors LLC boosted its position in shares of USANA Health Sciences by 137.7% in the fourth quarter. Teachers Advisors LLC now owns 217,677 shares of the company’s stock worth $13,322,000 after buying an additional 126,090 shares in the last quarter. Norges Bank bought a new position in shares of USANA Health Sciences during the fourth quarter worth approximately $6,855,000. FMR LLC boosted its position in shares of USANA Health Sciences by 7.1% in the first quarter. FMR LLC now owns 1,538,110 shares of the company’s stock worth $88,595,000 after buying an additional 102,086 shares in the last quarter. Finally, State Street Corp boosted its position in shares of USANA Health Sciences by 104.3% in the fourth quarter. State Street Corp now owns 190,838 shares of the company’s stock worth $11,676,000 after buying an additional 97,430 shares in the last quarter. Institutional investors own 44.21% of the company’s stock.

Shares of USANA Health Sciences, Inc. (USNA) opened at 64.75 on Wednesday. The stock has a market capitalization of $1.59 billion, a price-to-earnings ratio of 16.35 and a beta of 1.13. The stock’s 50 day moving average price is $64.22 and its 200-day moving average price is $60.96. USANA Health Sciences, Inc. has a 12 month low of $52.55 and a 12 month high of $75.00.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.06 by $0.08. USANA Health Sciences had a net margin of 9.71% and a return on equity of 31.84%. The firm had revenue of $257.10 million for the quarter, compared to the consensus estimate of $273.61 million. During the same quarter last year, the company earned $2.07 earnings per share. The firm’s revenue was down .5% on a year-over-year basis. Equities analysts forecast that USANA Health Sciences, Inc. will post $3.95 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “First Quadrant L P CA Buys 3,459 Shares of USANA Health Sciences, Inc. (USNA)” was first published by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.dailypolitical.com/2017/07/26/first-quadrant-l-p-ca-buys-3459-shares-of-usana-health-sciences-inc-usna.html.

USNA has been the topic of a number of recent research reports. Pivotal Research restated a “hold” rating and set a $55.00 price objective (down previously from $75.00) on shares of USANA Health Sciences in a research note on Monday, May 1st. Zacks Investment Research raised USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Wednesday, April 12th. Finally, BidaskClub lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Tuesday, June 20th.

In related news, Director Myron W. Wentz sold 40,000 shares of the stock in a transaction dated Wednesday, July 5th. The shares were sold at an average price of $64.15, for a total value of $2,566,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Paul A. Jones sold 9,851 shares of the stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $64.50, for a total transaction of $635,389.50. Following the completion of the sale, the insider now owns 6,020 shares of the company’s stock, valued at approximately $388,290. The disclosure for this sale can be found here. Insiders have sold 134,735 shares of company stock valued at $8,371,021 over the last 90 days. Corporate insiders own 53.20% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.